. Author manuscript; available in PMC: 2016 Aug 1.

Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Feb 28;13(8):1487–1495. doi: 10.1016/j.cgh.2015.02.038

TABLE 2.

Colorectal cancer screening rates according to modality and race/ethnicity.

CRC screening modality	White (N = 605,958)	African American (N = 52,911)	Latino (N = 86,990)	Asian (N = 72,720)	Other (N = 51,635)	p-value
Colonoscopy ^†	391075 (64.5%)	26166 (49.5%)	28920 (33.2%)	49545 (68.1%)	25894 (50.1%)	< .001 ^*
Sigmoidoscopy only ^†	15903 (2.6%)	1187 (2.2%)	2649 (3.0%)	1129 (1.6%)	781 (1.5%)	.83 ^*
Fecal-based test only ^‡	33941 (5.6%)	7285 (13.8%)	6250 (7.2%)	2295 (3.2%)	4851 (9.4%)	.12 ^*
Sigmoidoscopy ^† and fecal-based test ^‡	11582 (1.9%)	384 (0.7%)	1805 (2.1%)	0 (0%)	2048 (4.0%)	.29 ^*
Any screening test	452501 (74.7%)	35022 (66.2%)	39624 (45.6%)	52969 (72.8%)	33574 (65.0%)	.002 ^*

Data are presented as n (%).

CRC, colorectal cancer.

Chi-squared test.

^†

Performed within past 5 years.

^‡

Performed within past year.